Why Is Clinical Trial Participation Vital for Diffuse Large B-Cell Lymphoma Patients?
https://vimeo.com/818533113 Why is it vital for diffuse large B-cell lymphoma (DLBCL) patients to participate in clinical trials? Expert Dr. Nirav Shah from the Medical College of Wisconsin shares his perspective…
When Should CAR-T Therapy Be Considered for Relapsed/Refractory DLBCL Patients?
https://vimeo.com/818533127 When can relapsed/refractory diffuse large B-cell lymphoma (DLBCL) patients benefit from CAR T-cell therapy? Expert Dr. Nirav Shah from the Medical College of Wisconsin explains study results that compared…
What DLBCL Treatment Options Are There for Relapsed/Refractory Patients?
https://vimeo.com/818533137 What can relapsed/refractory diffuse large B-cell lymphoma (DLBCL) patients look to for treatment options? Expert Dr. Nirav Shah from the Medical College of Wisconsin shares research updates for relapsed/refractory…
How Can Patients Overcome Noted Diffuse Large B-Cell Lymphoma Disparities?
https://vimeo.com/818533161 How can diffuse large B-cell lymphoma (DLBCL) patients overcome noted care disparities? Expert Dr. Nirav Shah from Medical College of Wisconsin explains some common factors that impact DLBCL care…
How Can Your Diffuse Large B-Cell Lymphoma Care Team Help in Treatment Decisions?
https://vimeo.com/818533178 How can diffuse large B-cell lymphoma (DLBCL) treatment decisions be aided by your care team? Expert Dr. Nirav Shah from the Medical College of Wisconsin explains key factors that…
How Do Different Diffuse Large B-Cell Lymphoma Subtypes Impact Treatment Options?
https://vimeo.com/818533201 How are diffuse large B-cell lymphoma (DLBCL) subtypes impacting treatment options? Expert Dr. Nirav Shah from the Medical College of Wisconsin explains key factors that help determine DLBCL subtype…
What Promising Treatments Are Available for Diffuse Large B-Cell Lymphoma Patients?
https://vimeo.com/818533221 What promising diffuse large B-cell lymphoma (DLBCL) treatments are available for patients? Expert Dr. Nirav Shah from Medical College of Wisconsin shares an update on emerging research and patient…
What Is the Ann Arbor Staging System for Diffuse Large B-Cell Lymphoma?
https://vimeo.com/818533235 What is the diffuse large B-cell lymphoma (DLBCL) system called Ann Arbor staging? Expert Dr. Nirav Shah from the Medical College of Wisconsin explains how DLBCL differs from other…
How Is Diffuse Large B-Cell Lymphoma Explained to a Newly Diagnosed Patient?
https://vimeo.com/818533251 How do diffuse large B-cell lymphoma (DLBCL) experts explain this cancer to newly diagnosed patients? Expert Dr. Nirav Shah shares his perspective on how he leads patients through their…
What Does Breast Cancer Hormone Receptor Status Mean?
https://vimeo.com/817356566 There are many subclassifications of breast cancer—including a patient’s hormone receptor status. Expert Dr. Jame Abraham defines hormone receptor status and explains the potential impact on breast cancer treatment…
How Do Genomic Testing Results Impact Breast Cancer Treatment Options?
https://vimeo.com/817356512 Understanding a breast cancer patient’s individual disease is vital to personalizing their care. Dr. Jame Abraham explains how genomic testing results could impact a patient’s treatment path. Dr. Jame…
What Is a Breast Cancer Genetic Mutation?
